Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
PETQ

PETQ - PetIQ Inc Stock Price, Fair Value and News

$30.98 
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

PETQ Price Action

Last 7 days

0.2%


Last 30 days

0.8%


Last 90 days

41.5%


Trailing 12 Months

66.5%

PETQ RSI Chart

PETQ Valuation

Market Cap

911.1M

Price/Earnings (Trailing)

69.06

Price/Sales (Trailing)

0.8

EV/EBITDA

65.41

Price/Free Cashflow

45.06

PETQ Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PETQ Fundamentals

PETQ Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

4.58%

Rev. Growth (Qtr)

6.65%

PETQ Earnings

Earnings (TTM)

13.2M

Earnings Growth (Yr)

61.83%

Earnings Growth (Qtr)

2.78%

PETQ Profitability

EBT Margin

1.24%

Return on Equity

5.07%

Return on Assets

1.48%

Free Cashflow Yield

2.22%

PETQ Investor Care

Shares Dilution (1Y)

1.12%

Diluted EPS (TTM)

0.4

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.1B1.1B00
2023936.3M998.8M1.1B1.1B
2022953.9M934.9M934.1M921.5M
2021847.6M851.6M900.1M932.5M
2020747.8M794.1M770.2M780.1M
2019562.0M611.5M666.1M709.4M
2018314.7M398.7M469.5M528.6M
2017214.9M240.8M259.7M266.7M
2016204.3M202.9M201.5M200.2M
2015000205.7M
PETQ
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
 CEO
 WEBSITEhttps://petiq.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES1076

PetIQ Inc Frequently Asked Questions


What is the ticker symbol for PetIQ Inc? What does PETQ stand for in stocks?

PETQ is the stock ticker symbol of PetIQ Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of PetIQ Inc (PETQ)?

As of Fri Oct 25 2024, market cap of PetIQ Inc is 911.06 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PETQ stock?

You can check PETQ's fair value in chart for subscribers.

Is PetIQ Inc a good stock to buy?

The fair value guage provides a quick view whether PETQ is over valued or under valued. Whether PetIQ Inc is cheap or expensive depends on the assumptions which impact PetIQ Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PETQ.

What is PetIQ Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Oct 25 2024, PETQ's PE ratio (Price to Earnings) is 69.06 and Price to Sales (PS) ratio is 0.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PETQ PE ratio will change depending on the future growth rate expectations of investors.